CorMedix Inc. (CRMD)
NASDAQ: CRMD
· Real-Time Price · USD
12.91
0.30 (2.38%)
At close: Aug 15, 2025, 3:59 PM
12.93
0.15%
After-hours: Aug 15, 2025, 07:54 PM EDT
CorMedix Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 121.48M | 82.55M | 43.47M | 12.57M | 1.11M | 304.11K | 304.11K | 29.7K | 36.52K | 57.77K | 65.41K | 92.1K | 123.37K | 110.31K | 190.94K | 190.25K | 245.19K | 253.44K |
Cost of Revenue | 5.32M | 3.97M | 3.19M | 2.07M | 1.43M | 974.66K | 205.56K | 152.46K | 102.07K | 51.65K | 3.73K | 51.34K | 75.03K | 89.13K | 148.94K | 158.16K | 212.91K | 217.67K |
Gross Profit | 116.16M | 78.59M | 40.28M | 10.5M | -323.52K | -670.55K | 98.55K | -122.76K | -65.55K | 6.12K | 61.67K | 40.77K | 48.34K | 21.19K | 42K | 32.09K | 32.27K | 35.77K |
Operating Income | 49.32M | 14.47M | -22.36M | -50.96M | -58.14M | -54.64M | -48.96M | -41.68M | -38.17M | -34.61M | -30.62M | -30.01M | -31.62M | -29.26M | -29.44M | -27.74M | -25.78M | -28.82M |
Interest Income | 2.46M | 2.29M | 2.58M | 2.99M | 3.2M | 3.09M | 2.68M | 1.95M | 1.27M | 758.65K | 326.02K | 146.88K | 56.48K | 24.48K | 14.4K | 12.98K | 20.8K | 56.06K |
Pretax Income | 51.68M | 17.18M | -19.32M | -47.54M | -54.51M | -51.63M | -46.34M | -39.79M | -36.9M | -33.82M | -30.29M | -29.87M | -31.59M | -29.28M | -29.46M | -27.76M | -25.79M | -28.86M |
Net Income | 51.16M | 17.18M | -17.93M | -46.15M | -53.12M | -50.24M | 394.84M | 401.56M | 404.56M | 408.23M | -29.42M | -29.18M | -31M | -28.03M | -28.21M | -26.51M | -24.54M | -23.69M |
Selling & General & Admin | 3.16B | 57.81M | 58.7M | 56.65M | 51.12M | 43.19M | 35.75M | 28M | 24.82M | 22.86M | 20.01M | 18.98M | 18.19M | 16.5M | 16.35M | 15.58M | 15.44M | 15.31M |
Research & Development | 2.45B | 6.3M | 3.94M | 4.5M | 6.44M | 10.59M | 13.16M | 13.71M | 13.38M | 11.8M | 10.68M | 11.07M | 13.47M | 12.78M | 13.13M | 12.19M | 10.38M | 13.54M |
Other Expenses | -5.54B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 66.85M | 64.11M | 62.64M | 61.15M | 57.57M | 53.77M | 48.9M | 41.71M | 38.21M | 34.66M | 30.69M | 30.06M | 31.67M | 29.28M | 29.48M | 27.77M | 25.81M | 28.86M |
Interest Expense | 36.69K | 36.58K | 36.41K | 32.95K | 36.06K | 35.35K | 34.3K | 36.52K | 32.18K | 29.91K | 26.52K | 23.12K | 19.72K | 16.14K | 15.94K | 15.89K | 18.31K | 32.13K |
Selling & Marketing Expenses | -6.36B | 26.87M | 28.74M | 28.63M | 25.94M | 21.81M | 15.47M | 7.31M | 3.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 72.17M | 68.08M | 65.83M | 63.22M | 58.95M | 54.64M | 48.96M | 41.71M | 38.21M | 34.67M | 30.69M | 30.06M | 31.69M | 29.32M | 29.58M | 27.93M | 26.03M | 29.07M |
Income Tax Expense | 521.51K | n/a | -1.39M | -1.39M | -1.39M | -1.41M | -441.19M | -441.37M | -441.48M | -442.05M | -872.27K | -686.62K | -573.02K | -1.24M | -1.23M | -1.31M | -1.31M | -5.23M |
Shares Outstanding (Basic) | 67.93M | 65.24M | 61.51M | 58.83M | 57.62M | 57.5M | 57.39M | 56.55M | 45.37M | 44.03M | 41.18M | 40.32M | 39.76M | 38.25M | 37.16M | 38.11M | 38.08M | 36.33M |
Shares Outstanding (Diluted) | 71.92M | 68.98M | 61.51M | 58.83M | 57.62M | 57.5M | 57.39M | 56.55M | 45.37M | 44.09M | 41.86M | 41.18M | 39.76M | 38.25M | 38.11M | 38.11M | 38.08M | 36.33M |
EPS (Basic) | 0.78 | 0.24 | -0.33 | -0.81 | -0.93 | -0.93 | 9.10 | 9.17 | 9.17 | 9.23 | -0.73 | -0.75 | -0.8 | -0.73 | -0.75 | -0.73 | -0.73 | -0.75 |
EPS (Diluted) | 0.75 | 0.22 | -0.33 | -0.81 | -0.93 | -0.93 | 9.09 | 9.16 | 9.17 | 9.23 | -0.72 | -0.73 | -0.79 | -0.72 | -0.74 | -0.73 | -0.73 | -0.75 |
EBITDA | 52.33M | 17.78M | -18.83M | -47.18M | -54.21M | -51.39M | -46.11M | -39.55M | -36.66M | -33.58M | -30.09M | -29.7M | -31.45M | -29.19M | -29.37M | -27.62M | -25.65M | -28.7M |
EBIT | 51.72M | 17.22M | -19.29M | -47.51M | -54.47M | -51.6M | -46.3M | -39.76M | -36.87M | -33.79M | -30.26M | -29.85M | -31.57M | -29.26M | -29.44M | -27.74M | -25.77M | -28.82M |
Depreciation & Amortization | 611.44K | 561.83K | 457.36K | 339.03K | 276.18K | 213.59K | 205.56K | 206.43K | 207.03K | 207.87K | 209.04K | 284.79K | 251.58K | 213.95K | 177.02K | 127.57K | 118.52K | 123.96K |